文献速递泌尿系结石

完全输尿管内支架置入与传统支架置入缓解输尿管支架相关症状的疗效与安全性:一项随机、前瞻性、单盲、多中心临床试验

Efficacy and Safety of Complete Intraureteral Stent Placement versus Conventional Stent Placement in Relieving Ureteral Stent Related Symptoms: A Randomized, Prospective, Single Blind, Multicenter Clinical Trial.
PubMed 文献 · J Urol · 2019-06-07

该随机、前瞻性、单盲、多中心临床试验将85例碎石术后需置入输尿管支架的患者分为完全输尿管内支架组与传统支架组,支架留置至术后第14天。结果显示完全输尿管内支架组在术后第3天和第14天的疼痛评分、总I-PSS评分及镇痛药总用量均显著低于传统支架组,而SF-36和总OABSS评分无显著差异,两组并发症发生率无差异。

要点

  • 完全输尿管内支架组术后第3天疼痛评分4.85 vs 传统组9.78(p=0.003),第14天3.15 vs 6.20(p=0.014)。
  • 完全输尿管内支架组总I-PSS评分第3天10.41 vs 传统组14.90(p=0.006),第14天11.67 vs 16.10(p=0.022)。
  • 完全输尿管内支架组镇痛药总用量19.23 vs 传统组88.54 mg(p<0.001),两组并发症发生率无差异。

核心结论

  • 完全输尿管内支架置入可能与传统支架置入相比减少输尿管支架相关不适。
  • 这种新的置入方法可行且安全,可立即用于日常临床实践。

研究设计与样本

  • 随机、前瞻性、单盲、多中心临床试验,纳入85例碎石术后需置入输尿管支架的患者,随机分为完全输尿管内支架组或传统支架组,支架留置至术后第14天,最终分析80例患者的记录。

主要发现

  • 完全输尿管内支架组 vs 传统支架组术后第3天疼痛评分4.85 vs 9.78(p=0.003),术后第14天3.15 vs 6.20(p=0.014)。
  • 完全输尿管内支架组 vs 传统支架组总I-PSS评分术后第3天10.41 vs 14.90(p=0.006),术后第14天11.67 vs 16.10(p=0.022)。
  • 完全输尿管内支架组 vs 传统支架组镇痛药总用量19.23 vs 88.54 mg(p<0.001)。
  • SF-36和总OABSS评分差异无统计学显著差异。
  • 亚组分析显示完全输尿管内支架组在术后第3天和第14天腹股沟和膀胱区域疼痛评分、I-PSS中的排空不全和日间尿频、OABSS中的生活质量指数和日间尿频均显著优于传统支架组(所有p<0.05)。

临床怎么用

  • 作者认为完全输尿管内支架置入可能与传统支架置入相比减少输尿管支架相关不适,该方法可行且安全,可立即用于日常临床实践。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We compared the efficacy and safety of complete and conventional stent placement to relieve ureteral stent related symptoms. MATERIALS AND METHODS: We randomized 85 patients who required ureteral stent placement after lithotripsy into an intraureteral or a conventional stent placement group. The ureteral stent remained in place until postoperative day 14. We evaluated scores on the visual analog scale pain, the SF-36 (36-Item Short-Form Health Survey), the I-PSS (International Prostate Symptom Score) and the OABSS (Overactive Bladder Symptom Score) on postoperative days 3 and 14. We also assessed the total amount of analgesics administered and stent related complications. RESULTS: Overall the records of 80 patients were analyzed. Pain scores were significantly lower in the intraureteral vs the conventional stent placement group (postoperative days 3 and 14, 4.85 vs 9.78, p = 0.003, and 3.15 vs 6.20, p = 0.014, respectively). The total I-PSS score (postoperative days 3 and 14, 10.41 vs 14.90, p = 0.006, and 11.67 vs 16.10, p = 0.022, respectively) and total analgesic use (19.23 vs 88.54 mg, p <0.001) were significantly lower in the intraureteral group. However, differences in the SF-36 and the total OABSS scores did not significantly differ. On subgroup analysis the pain score in the groin and bladder areas, incomplete emptying and daytime frequency on the I-PSS, the quality of life index and daytime frequency on the OABSS were significantly better in the intraureteral stent placement group than the conventional stent placement group on postoperative days 3 and 14 (all p <0.05). There was no difference in the complication rate between the 2 groups. CONCLUSIONS: Intraureteral stent placement may be associated with less ureteral stent related discomfort than conventional stent placement. This novel placement method is feasible and safe, and it can be immediately used in daily clinical practice.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Yoshida T, Inoue T, Taguchi M, et al. Efficacy and Safety of Complete Intraureteral Stent Placement versus Conventional Stent Placement in Relieving Ureteral Stent Related Symptoms: A Randomized, Prospective, Single Blind, Multicenter Clinical Trial. J Urol. 2019. PMID: 30829132. doi:10.1097/JU.0000000000000196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。